Description
A panaxatriol saponin that has diverse in vitro and in vivo effects, including vasorelaxant, antioxidant, antihyperlipidemic, and angiogenic actions; improves the effectiveness of chemotherapeutic agents by decreasing the expression of Multidrug Resistance Protein 1 and inhibiting P-glycoprotein
Formal name: (6α)-20-(β-D-glucopyranosyloxy)-3β,12β-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
Synonyms: Chikusetsusaponin IVc|NSC 308877|Panaxoside Re|Sanchinoside Re
Molecular weight: 947.2
CAS: 52286-59-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Natural Products|Ginsenosides||Product Type|Biochemicals|Natural Products|Glycosides||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Cancer|Multidrug Resistance||Research Area|Cardiovascular System|Vasculature|Angiogenesis||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity